Top Markets
Coin of the day
Medios AG Medios AG

Medios AG

ILM1
Rang in Aktien #15688
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical... Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions. The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. Medios AG is founded in 2015 and was headquartered in Berlin, Germany.
Aktienkurs
$13.21
Marktkapitalisierung
$337.03M
Veränderung (1 Tag)
-0.36%
Veränderung (1 Jahr)
-28.32%
Land
DE
Handel Medios AG (ILM1)

Kategorie

Kursverlauf für Medios AG (ILM1)
Höchster Schlusskurs: $13.21 am 2026-09-01

Niedrigster Schlusskurs: $8.53 am 2007-12-01
Kursverlauf der Aktie von Medios AG von 2007 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -2.30%
2025 26.14%
2024 -25.97%
2023 -10.94%
2022 -53.09%
2021 -6.48%
2020 57.01%
2019 87.34%
2018 -23.27%
2017 135.26%
2016 1,459.53%
2015 -11.69%
2014 -9.95%
2013 4.54%
2012 -0.36%
2011 2.84%
2010 1.04%
2009 -62.54%
2008 -80.20%
2007 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$911.76 32.79%
US
$328.80 12.75%
US
$239.97 61.29%
US
$187.22 0.00%
US
$1.92 -6.49%
AU